Ptc Therapeutics Stock Market Value
| PTCT Stock | USD 43.23 0.34 0.79% |
| Symbol | PTC |
PTC Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PTC Therapeutics. If investors know PTC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PTC Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.94) | Revenue Per Share 11.787 | Quarterly Revenue Growth 0.001 | Return On Assets (0.05) | Return On Equity (77.40) |
The market value of PTC Therapeutics is measured differently than its book value, which is the value of PTC that is recorded on the company's balance sheet. Investors also form their own opinion of PTC Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is PTC Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PTC Therapeutics' market value can be influenced by many factors that don't directly affect PTC Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PTC Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if PTC Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PTC Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
PTC Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PTC Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PTC Therapeutics.
| 06/04/2023 |
| 11/25/2024 |
If you would invest 0.00 in PTC Therapeutics on June 4, 2023 and sell it all today you would earn a total of 0.00 from holding PTC Therapeutics or generate 0.0% return on investment in PTC Therapeutics over 540 days. PTC Therapeutics is related to or competes with Krystal Biotech, Sarepta Therapeutics, Iovance Biotherapeutics, Madrigal Pharmaceuticals, Blueprint Medicines, Viking Therapeutics, and Hepion Pharmaceuticals. PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of med... More
PTC Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PTC Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PTC Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.81 | |||
| Information Ratio | 0.0914 | |||
| Maximum Drawdown | 23.95 | |||
| Value At Risk | (4.33) | |||
| Potential Upside | 5.65 |
PTC Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PTC Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PTC Therapeutics' standard deviation. In reality, there are many statistical measures that can use PTC Therapeutics historical prices to predict the future PTC Therapeutics' volatility.| Risk Adjusted Performance | 0.1069 | |||
| Jensen Alpha | 0.2471 | |||
| Total Risk Alpha | (0.11) | |||
| Sortino Ratio | 0.1126 | |||
| Treynor Ratio | 0.2777 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PTC Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PTC Therapeutics Backtested Returns
PTC Therapeutics appears to be very steady, given 3 months investment horizon. PTC Therapeutics retains Efficiency (Sharpe Ratio) of 0.11, which implies the firm had a 0.11% return per unit of risk over the last 3 months. We have found thirty technical indicators for PTC Therapeutics, which you can use to evaluate the volatility of the company. Please evaluate PTC Therapeutics' market risk adjusted performance of 0.2877, and Semi Deviation of 2.43 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, PTC Therapeutics holds a performance score of 8. The company owns a Beta (Systematic Risk) of 1.58, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, PTC Therapeutics will likely underperform. Please check PTC Therapeutics' jensen alpha, skewness, relative strength index, as well as the relationship between the value at risk and day median price , to make a quick decision on whether PTC Therapeutics' current price history will revert.
Auto-correlation | -0.39 |
Poor reverse predictability
PTC Therapeutics has poor reverse predictability. Overlapping area represents the amount of predictability between PTC Therapeutics time series from 4th of June 2023 to 29th of February 2024 and 29th of February 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PTC Therapeutics price movement. The serial correlation of -0.39 indicates that just about 39.0% of current PTC Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.39 | |
| Spearman Rank Test | -0.39 | |
| Residual Average | 0.0 | |
| Price Variance | 19.74 |
PTC Therapeutics lagged returns against current returns
Autocorrelation, which is PTC Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting PTC Therapeutics' stock expected returns. We can calculate the autocorrelation of PTC Therapeutics returns to help us make a trade decision. For example, suppose you find that PTC Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
PTC Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If PTC Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if PTC Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in PTC Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
PTC Therapeutics Lagged Returns
When evaluating PTC Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of PTC Therapeutics stock have on its future price. PTC Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, PTC Therapeutics autocorrelation shows the relationship between PTC Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in PTC Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for PTC Stock Analysis
When running PTC Therapeutics' price analysis, check to measure PTC Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PTC Therapeutics is operating at the current time. Most of PTC Therapeutics' value examination focuses on studying past and present price action to predict the probability of PTC Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PTC Therapeutics' price. Additionally, you may evaluate how the addition of PTC Therapeutics to your portfolios can decrease your overall portfolio volatility.